Treace Medical officer reports tax share withholding

Treace Medical Concepts Chief Legal & Compliance Officer Scot Michael Elder reported routine tax-withholding dispositions of company stock.

Accepted by SEC EDGAR 03/11/2026 - 09:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Treace Medical Concepts Chief Legal & Compliance Officer Scot Michael Elder reported routine tax-withholding dispositions of company stock. On two March dates, a total of 1,850 shares of common stock were delivered to cover tax obligations. Following these transactions, Elder directly held 794,936 common shares. Footnotes indicate these holdings include restricted stock units.

Insider Trade Summary

Exercise Price or Tax Liability: 1,850 shares

Exercise Price or Tax Liability 2 txns

Insider Elder Scot Michael

Role Chief Legl & Comp Off, CorpSec

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,675	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	175	$0.00	$0.00

Holdings After Transaction: Common Stock — 794,936 shares (Direct)

Holdings Before and After: Common Stock, 796,786 to 794,936 shares (Direct)

Footnotes (2)

1. F1. Includes 640,752 restricted stock units.
2. F2. Includes 633,877 restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TMCI executive Scot Michael Elder report in this Form 4?

Scot Michael Elder reported tax-withholding dispositions of Treace Medical Concepts stock. Two F-code transactions in March transferred 1,850 common shares to satisfy tax obligations, a non-market event. He continued to hold 794,936 common shares afterward, including restricted stock units.

Were the TMCI Form 4 transactions open-market sales or routine tax withholding?

The transactions were routine tax-withholding dispositions, not open-market sales. Both are coded "F" and described as payment of tax liability by delivering securities, meaning shares were withheld to cover taxes rather than sold in the market.

How many TMCI shares were used to cover taxes in the latest filing?

A total of 1,850 Treace Medical Concepts common shares were used to cover taxes. The Form 4 shows 1,675 shares disposed on one date and 175 shares on another, both as tax-withholding transactions classified under code F.

How many TMCI shares does Scot Michael Elder hold after these transactions?

After the reported transactions, Elder directly holds 794,936 TMCI common shares. This post-transaction balance reflects his continuing equity position in the company and, according to the footnotes, includes restricted stock units within the total amount.

What does transaction code F mean in the TMCI Form 4 filing?

Transaction code F indicates shares used to pay exercise price or tax liability. In this TMCI filing, it means common shares were delivered to satisfy tax obligations tied to equity compensation, rather than being voluntarily sold on the open market.

Do Scot Michael Elder’s TMCI holdings include restricted stock units (RSUs)?

Yes, the reported holdings include restricted stock units. Footnotes specify that the common stock totals disclosed in the Form 4 encompass RSUs, indicating part of Elder’s TMCI equity position is in the form of time-based or performance-based stock awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elder Scot Michael

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FL 32081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legl & Comp Off, CorpSec

3. Date of Earliest Transaction (Month/Day/Year)
03/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/08/2026		F		175	D	$0	796,611(1)	D
Common Stock	03/10/2026		F		1,675	D	$0	794,936(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 640,752 restricted stock units.

2. Includes 633,877 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Scot Elder	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.